|
CorMedix Amends and Restates Outstanding Securities to Remove Provisions …
MarketWatch … C-3, D and E preferred stock and related warrants, as well as the warrants issued in its March 2014 common stock and warrant financing, to remove anti-dilution, price reset and certain change of control provisions that caused those securities to be … |
